Crowdonomics
WatchlistPortfolio
Mahzi Therapeutics

Reg CF · Preferred Stock · Jun 2026

OpenReached targetReg CFPreferred Equity
via WeFunder · last checked Oct 8, 2026View campaign
Raised
$358.9K / $1.2M max
30% of ceiling · target hit day 71
Investors
148
$2.4K avg
Momentum
$3K/day
best $106K · 83 days left

Raised over time

Cumulative raisedInvestors
$359K$179K$0
148740
Jun 17, 2026 · openedOct 8, 2026 · latest
Target ($50K) hit — Aug 27, 2026, day 71Deadline Dec 31, 2026 — 84 days out

Left axis: cumulative dollars raised. Right axis: cumulative investors. Live figures via WeFunder, last checked Oct 8, 2026; investor counts may lag the platform by up to a day.

Financials disclosed in this offering

FY2024–FY2025 · hover for source
$0
−$11.9M
FY2024
$0
−$18.7M
FY2025
RevenueNet income
Metric
FY2024 audited
FY2025 audited
Income statement
Revenue
$0
$0
Cost of goods sold
$0
$0
Net income
-$11,885,773
-$18,656,306
Taxes paid
$0
$0
Balance sheet
Cash
$10,260,277
$10,695,753
Accounts receivable
$0
$0
Total assets
$18,971,450
$11,638,540
Short-term debt
$2,058,254
$6,760,112
Long-term debt
$0
$1,137,377
Total liabilities
$2,058,254
$7,897,489
Other
Headcount
—
14

The fiscal years the issuer disclosed in this offering’s filing, as filed. Full history on the company page.

Deal terms

Pre-money$87.9M
Price / share$3.47
Shares offered14,410

Post-money is computed as pre-money + amount raised, so it moves while the round is open — it’s shown once the round closes.

Offering details

Target$50,000
Max$1,200,000
Min investment—
OpenedJun 17, 2026
DeadlineDec 31, 2026
Days active114
Days to deadline83

Links & provenance

Campaign pagePitch videoSEC filingWeFunder listing
Source: SEC EDGAR
0001888808-26-000001
Last synced Oct 8, 2026

About this data. Raised amounts and investor counts come from the platform listing and may lag or be restated; SEC-reported totals can differ until the next Form 1-Z/C-U. Post-money valuation is computed as pre-money plus amount raised and is shown once the round closes — it is not a traded price. Financial statements are as reported by the issuer. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.